Navigation Links
Pluristem to Present Two Scientific Posters at the International,Society for Cellular Therapy

NEW YORK--(BUSINESS WIRE)--May 2, 2007 - Pluristem Life Systems, Inc. (OTCBB:PLRS), a cell therapy Company dedicated to the commercialization of products for a variety of indications, announced today that it will present two scientific posters at the 13th Annual Meeting of the International Society for Cellular Therapy (ICST), June 24-27, 2007 in Sydney Australia.

Pluristem CEO and Chairman, Mr. Zami Aberman commented, "We are receiving more attention from the scientific community as our research and development team continues to successfully show how innovative our Placenta eXpanded (PLX) cells are. These PLX cells are mesenchymal stem cells expanded in our proprietary 3D PluriX(TM) Bioreactor System."

Pluristem's presentations are entitled, "Expansions of cord blood (CB) derived unseparated hematopoietic stem cells (HSC) co-cultured with mesenchymal cells growing in three dimensional (3-D) mode" and "Promotion of CD34+ cells engraftment using mesenchymal stromal cells expanded ex vivo in bioreactor containing high-density 3-D culture."

Pluristem will also attend the 2007 BIO International Convention being held at the Boston Convention & Exhibition Center from May 6-9, 2007. BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations.

Mr. Aberman added, "These venues provide us with several opportunities to interact with researchers, laboratory professional, physicians, regulatory specialists, business leaders, investments professionals and business colleagues, all working or interested in the cellular therapy sector."

About Pluristem

Pluristem Life Systems, Inc. is a Company dedicated to the commercialization of non-personalized (allogeneic) stem cell therapy products for the treatment of numerous severe degenerative, malignant and autoimmune disorders.
'"/>




Page: 1 2 3

Related medicine technology :

1. Pluristems PLX Cells Demonstrate Potential to Treat Parkinsons Disease
2. The Past, Present and Future of HLA Typing
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
11. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
Post Your Comments:
(Date:12/14/2009)... MOUNTAIN VIEW, Calif., Dec. 14 Alexza Pharmaceuticals, ... has submitted its New Drug Application (NDA) for Staccato® ... (FDA). AZ-004 is an inhalation product candidate being ... with schizophrenia or bipolar disorder. The IND for ... in August 2005. ,, "AZ-004 has delivered a predictable ...
(Date:12/14/2009)... Dec. 14 Zargis Medical Corp., a ... ) and a spin-off from Siemens Corporate Research ... it has begun selling its award-winning Zargis Cardioscan(TM) ... Cardioscan and its accompanying Bluetooth®-enabled electronic stethoscope were ... "2009 Innovation of the Year." Cardioscan ...
(Date:12/14/2009)... -- Environmental health advocates hope that U.S. FDA ... of bisphenol A (BPA), a synthetic sex hormone ... other illnesses, in time for Christmas. ,, ... scientist, Natural Resources Defense Council : "Just ... advice, FDA must rely on the advice of ...
Breaking Medicine Technology:Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 2Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 3Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 4Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 5Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 6Zargis Cardioscan 'The Intelligent Stethoscope' Now Available on Amazon.com 2Toxic Chemical bisphenol A Still Not Banned By FDA; Schumer, Gillibrand Call for Ban; Govt Official Warns Public 2Atlanta Falcons Chauncey Davis Honors 2009 Community Impact Awardees 57922 1Atlanta Falcons Chauncey Davis Honors 2009 Community Impact Awardees 57922 2Radware Prevents Network Downtime for Carolinas HealthCare System One of the Largest Healthcare Systems in the U S 57918 1Radware Prevents Network Downtime for Carolinas HealthCare System One of the Largest Healthcare Systems in the U S 57918 2Radware Prevents Network Downtime for Carolinas HealthCare System One of the Largest Healthcare Systems in the U S 57918 3Radware Prevents Network Downtime for Carolinas HealthCare System One of the Largest Healthcare Systems in the U S 57918 4Radware Prevents Network Downtime for Carolinas HealthCare System One of the Largest Healthcare Systems in the U S 57918 5Yoga Sandals 28R 29 Footwear Steps up with Donations for Womens Health 57913 1Yoga Sandals 28R 29 Footwear Steps up with Donations for Womens Health 57913 2
... Ltd. (Nasdaq: XTLB ; TASE: XTL) today announced ... study of Bicifadine,-- a serotonin and norepinephrine reuptake inhibitor ... patients were randomized into,the study. Based on the completion ... complete the study in the next 4 months., ...
... Ariz., June 26 MedPredict has published a,new ... Insight &,Analysis: Lung Cancer," designed to provide critical ... stake in the market for diagnostics and,treatments in ... The big news at the recent American Society ...
Other Medicine Technology:XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain 2XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain 3Landscape for Lung Cancer Therapies is Focus of New Post-ASCO MedPredict Report 2
(Date:12/14/2009)... a statement of Matthew L. Myers, President, Campaign ... ,, The 2009 Monitoring the Future Survey released ... shows that the nation continues to make gradual ... slowed significantly compared to the dramatic gains early ... the survey also finds that smokeless tobacco use ...
(Date:12/14/2009)... be asked to approve naming the women,s hospital -- ... Hospital complex -- after Ted and Jane Von Voigtlander ... The University of Michigan Health System has received a ... Voigtlander Foundation, the largest gift ever made to the ... construction of a new women,s hospital. ,, The gift ...
(Date:12/14/2009)... A new study published by researchers from the University ... Fla., has found that cancer patients with dementia have ... alone, even after controlling for factors such as age, ... published in the early online edition of the journal ... a diagnosis of dementia shouldn,t discourage the use of ...
(Date:12/14/2009)... Professor of Nursing and Co-Director of the Statistics and ... Nursing, examined data from 2,923 adult participants in the ... not been diagnosed with diabetes. The survey, conducted by ... for Disease Control and Prevention, was designed to assess ... in the United States. , Using guidelines established ...
(Date:12/14/2009)... one step closer to developing a vaccine against the ... Ph.D., director of the Jefferson Vaccine Center, the researchers ... protected against the simian equivalent of the HIV virus ... Vaccine . , The researchers previously showed that a ... a chimeric HIV/SIV virus in monkeys. In this study, ...
Breaking Medicine News(10 mins):Health News:New Survey Shows Slow Decline in Youth Smoking, Troubling Increase in Smokeless Tobacco Use - Congress, States Must Step Up Tobacco Prevention Efforts 2Health News:New Survey Shows Slow Decline in Youth Smoking, Troubling Increase in Smokeless Tobacco Use - Congress, States Must Step Up Tobacco Prevention Efforts 3Health News:New Survey Shows Slow Decline in Youth Smoking, Troubling Increase in Smokeless Tobacco Use - Congress, States Must Step Up Tobacco Prevention Efforts 4Health News:New Survey Shows Slow Decline in Youth Smoking, Troubling Increase in Smokeless Tobacco Use - Congress, States Must Step Up Tobacco Prevention Efforts 5Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 2Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 3Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 4Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 5Health News:Study finds significantly worse outcomes in cancer patients with cognitive impairment 2Health News:Study finds significantly worse outcomes in cancer patients with cognitive impairment 3Health News:Study finds over 90 percent of people with gum disease are at risk for diabetes 2
... They help ward off osteoarthritis, study suggests , TUESDAY, ... health may also help keep knee cartilage healthy and ... studies on the issue have produced conflicting findings, the ... knee osteoarthritis, while other studies found that exercise may ...
... vascular disease , , FRIDAY, Oct. 5 (HealthDay News) -- ... problems achieving or sustaining erections, it may signal underlying ... than 18 million American men, according to a recent ... of Public Health. , And now a growing ...
... the largest,annual health and safety conferences on the ... Conference, is just around the,corner and there,s still ... 15-16 at the Hershey Lodge & Convention,Center, Hershey, ... business leaders, workers, educators and government leaders,from across ...
... Participants in Dallas-Ft. Worth, Hartford and Sacramento Markets, CHICAGO, Oct. 5 , Why: ... U.S. soldiers involved in the conflicts ... Traumatic Brain Injury (TBI), with 25 percent of blast ... blast survivors, leaving 5,500 service members ...
... MONTEREY, Calif., Oct. 5 Angel Flight West (AFW),awarded ... at,AFW,s 24th Anniversary Awards on Saturday, September 29th. Birely ... As an AFW pilot, John,flies people in need whose ... from medical facilities. Birely, like all AFW volunteer,pilots, donates ...
... Oct. 5 /PRNewswire-FirstCall/ - Bioniche Life Sciences,Inc., a research-based, technology-driven Canadian biopharmaceutical,company (TSX:BNC), will be discussing ... vaccine,during a: ... ... ...
Other Medicine News:Health News:Heart-Healthy Workouts Help Knees, Too 2Health News:Erectile Dysfunction: A Harbinger of Heart Trouble 2Health News:Erectile Dysfunction: A Harbinger of Heart Trouble 3Health News:Easter Seals Launches Program for Veterans Returning from Iraq and Afghanistan with Traumatic Brain Injuries 2Health News:Easter Seals Launches Program for Veterans Returning from Iraq and Afghanistan with Traumatic Brain Injuries 3Health News:Angel Flight West Recognizes Northern California Pilots at AFW 24th Anniversary Awards 2
Colloidal Gold Conjugated, Protein G - 12 OD...
Colloidal Gold Sol, 30 nm - 50 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Colloidal Gold Sol, 20 nm - 50 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
... PiGalileo™ Computer-Assisted Orthopedic ... PLUS Orthopedics combines ... and electro-mechanical instrument ... assist the surgeon ...
Medicine Products: